微创二尖瓣手术:当前证据与最佳实践模型
本文为叙述性综述,总结微创二尖瓣手术(MI-MVS)的术前诊断评估、当代手术技术、围术期管理、学习曲线及未来展望。MI-MVS可减少手术创伤、缩短住院时间、降低感染率并加快康复;视频辅助右小切口仍是最常用入路,全内镜与机器人辅助技术持续扩展。常规术前增强CT可改善患者选择与手术规划并降低卒中风险,仔细的患者选择与结构化导师指导对克服学习曲线至关重要。
要点
- MI-MVS可减少创伤、缩短住院、降低感染率并加快康复。
- 视频辅助右小切口最常用,全内镜与机器人辅助持续扩展。
- 常规术前增强CT改善选择与规划并降低卒中风险。
核心结论
- 在有经验的中心,MI-MVS已成为二尖瓣疾病确立且有效的治疗策略。
- 手术技术、影像工具、ERAS方案与机器人平台的持续进步有望进一步扩大其全球应用。
研究设计与样本
- 叙述性综述,检索当前MI-MVS相关文献,聚焦直视、视频辅助、全内镜与机器人辅助入路。
主要发现
- MI-MVS提供减少手术创伤、缩短住院时间、降低感染率与更快康复。
- 视频辅助右小切口仍是最常用入路,全内镜与机器人辅助技术持续扩展。
- 常规术前增强CT改善患者选择与手术规划并降低卒中风险。
- 仔细患者选择与结构化导师指导对克服学习曲线至关重要。
临床怎么用
- 术前应行增强CT以优化患者选择、手术规划并降低卒中风险。
- 优先选择视频辅助右小切口,有条件可开展全内镜或机器人辅助。
- 通过结构化培训与导师指导缩短学习曲线并优化结局。
- 围术期纳入ERAS方案以加快康复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Minimally invasive mitral valve surgery (MI-MVS) has evolved into a widely adopted surgical strategy for the treatment of mitral valve disease. This narrative review summarizes, the importance of preoperative diagnostic work-ups, contemporary surgical techniques, perioperative management, learning curve considerations, and future perspectives of MI-MVS. METHODS: A review of currently available literature on MI-MVS was performed, focusing on direct-vision, video-assisted, fully endoscopic, and robotic-assisted approaches. Best practice models regarding preoperative imaging, cannulation strategies, myocardial protection, mitral valve repair techniques, perioperative management, and Enhanced Recovery After Surgery (ERAS) protocols as well as important clinical outcome measures are discussed. RESULTS: MI-MVS provides reduced surgical trauma, shorter hospitalization, lower infection rates, and a faster recovery. Video-assisted right mini-thoracotomy remains the most commonly adopted approach, whereas fully endoscopic and robotic-assisted techniques continue to expand. Routine preoperative contrast-enhanced computed tomography improves patient selection as well as procedural planning and reduces the risk of stroke. Careful patient selection and structured mentorship are essential to overcome the learning curve. CONCLUSIONS: MI-MVS has become an established and effective treatment strategy for mitral valve disease in experienced centers. Ongoing advances in surgical technology, imaging tools, ERAS protocols, and robotic platforms are expected to further expand its global adoption. Standardized training pathways, careful patient selection, and experienced institutional mentorship remain critical for optimizing clinical outcomes.
引用
- Akansel S, Kofler M, Kempfert J, et al. Minimally invasive mitral valve surgery: Current evidence and best practice models. Eur J Cardiothorac Surg. 2026. PMID: 42776604. doi:10.1093/ejcts/ezag227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。